MENU
HRMY
AS OF
Nov 13, 04:59 PM (EDT)
Price
$34.29
Change
+$0.75 (+2.24%)
Capitalization
1.93B
110 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
HRMY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Harmony Biosciences Holdings (HRMY) Ownership - Who owns Harmony Biosciences Holdings?

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
630 West Germantown Pike
Phone
+1 484 539-9800
Employees
246
Web
https://www.harmonybiosciences.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.93B
P/E Ratio
10.58
Total Cash
565.27M
Projected Growth
N/A
Total Debt
172.1M
Revenue
772.53M
Risk (Beta)
1.50
Dividend Yield
N/A
Total Cash/Share
9.81
Total Debt/Equity
N/A
Revenue/Share
14.09 USD as % of share price

Fundamentals

HRMY
Capitalization
1.93B
P/E Ratio
10.58
Risk (Beta)
1.50
Dividend Yield
N/A
Total Cash
565M
Total Cash/Share
9.81
Total Debt
172M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
14.09%
Revenue
773M
ROE
N/A
Book Value
773M
P/B Ratio
2.31
Cash Flow
N/A
Earnings
3.17
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
3.84
Current Revenue Per Employee
748093.30
Dividends Per Share - Security
N/A
EBITDA
265M
Float
N/A
Float - Current
N/A
Gross Income Margin
80.97
Revenue To Assets
18.40
Shares Held By Institutions
2.67B
Shares Outstanding - Current
57.6M
Total Liabilities
335M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-2.528
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Swing Trader, Long Only with Inverse: Valuation Model for Energy Sector (TA&FA)Swing Trader, Long Only with Inverse: Valuation Model for Energy Sector (TA&FA)
Annualized Return+37%
VIEW DETAILSVIEW DETAILS
VIEW FOR FREEVIEW FOR FREE
HRMY
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. HRMY showed earnings on November 04, 2025. You can read more about the earnings report here.
View AI-Driven Trading for HRMY
A.I. Advisor
published General Information

General Information

a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
630 West Germantown Pike
Phone
+1 484 539-9800
Employees
246
Web
https://www.harmonybiosciences.com